First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

Clinical trial NCT06673667 · COMPLETED

Trial details

NCT number: NCT06673667
Sponsor: Kymera Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study

Start date: 2024-10-22
Primary completion: 2025-04-23
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.